Pu YS - Search Results

1

Quantitative analysis of messenger ribonucleic acid encoding natriuretic peptide receptors in aldosterone-producing adenoma.

Chen YM, Wu KD, Hung KY, Pu YS, Hsieh BS. Chen YM, et al. Among authors: pu ys. Mol Cell Endocrinol. 1995 Jun;111(2):139-46. doi: 10.1016/0303-7207(95)03556-m. Mol Cell Endocrinol. 1995. PMID: 7556875

2

Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.

Hong RL, Pu YS, Chu JS, Lee WJ, Chen YC, Wu CW. Hong RL, et al. Among authors: pu ys. Cancer Lett. 1995 Feb 10;89(1):81-7. doi: 10.1016/0304-3835(95)90161-2. Cancer Lett. 1995. PMID: 7533658

3

Tamoxifen enhances the chemosensitivity of bladder carcinoma cells.

Pu YS, Hsieh TS, Tsai TC, Cheng AL, Hsieh CY, Su IJ, Lai MK. Pu YS, et al. J Urol. 1995 Aug;154(2 Pt 1):601-5. doi: 10.1097/00005392-199508000-00078. J Urol. 1995. PMID: 7609145

4

Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.

Hour TC, Chen J, Huang CY, Guan JY, Lu SH, Hsieh CY, Pu YS. Hour TC, et al. Among authors: pu ys. Anticancer Res. 2000 Sep-Oct;20(5A):3221-5. Anticancer Res. 2000. PMID: 11062746

5

Expression of MDR-1 gene in transitional cell carcinoma and its correlation with chemotherapy response.

Pu YS, Tsai TC, Cheng AL, Tsai CY, Tseng NF, Su IJ, Hsieh CY, Lai MK. Pu YS, et al. J Urol. 1996 Jul;156(1):271-5. J Urol. 1996. PMID: 8648821

6

Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.

Pu YS, Hsieh TS, Cheng AL, Tseng NF, Su IJ, Hsieh CY, Lai MK, Tsai TC. Pu YS, et al. Br J Urol. 1996 Jan;77(1):76-85. doi: 10.1046/j.1464-410x.1996.82712.x. Br J Urol. 1996. PMID: 8653321

7

Expressions of E-cadherin and exon v6-containing isoforms of CD44 and their prognostic values in human transitional cell carcinoma.

Hong RL, Pu YS, Hsieh TS, Chu JS, Lee WJ. Hong RL, et al. Among authors: pu ys. J Urol. 1995 Jun;153(6):2025-8. J Urol. 1995. PMID: 7538603

8

Role of urinary cytology and urinary deoxyribonucleic acid flow cytometry in the diagnosis of bladder cancer.

Pu YS, Tsai TC, Hsieh TS, Huang HH, Kuo SH, Hsueh WC. Pu YS, et al. J Formos Med Assoc. 1994 Mar;93(3):216-21. J Formos Med Assoc. 1994. PMID: 7920061 Clinical Trial.

9

Serum level of immunosuppressive acidic protein in patients with urological malignancies.

Pu YS, Tsai TC, Chiu TY, Hsieh TS, Chen J, Chen SC, Lin MC, Hsu TC. Pu YS, et al. J Formos Med Assoc. 1991 May;90(5):498-503. J Formos Med Assoc. 1991. PMID: 1680990

10

Use of retinoic acids in the treatment of peripheral T-cell lymphoma: a pilot study.

Cheng AL, Su IJ, Chen CC, Tien HF, Lay JD, Chen BR, Pu YS, Hong RL, Shen MC, Wang CH, et al. Cheng AL, et al. Among authors: pu ys. J Clin Oncol. 1994 Jun;12(6):1185-92. doi: 10.1200/JCO.1994.12.6.1185. J Clin Oncol. 1994. PMID: 8201381 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

265 results

Search Page

Filters